Related Experiment Videos
A comparative analysis of response to vs. ORS + gelatin tannate pediatric patients with acute diarrhea
J Esteban Carretero1, F Durbán Reguera, S López-Argüeta Alvarez
1Department of Gastroenterology, Hospital Torrecárdenas, Almería, Spain. jcestebanc@saludalia.com
Insights
Adding gelatin tannate to oral rehydration salts (ORS) significantly reduced stool frequency in children with acute diarrhea. This treatment combination showed a greater stool decrease index compared to ORS alone.
Area of Science:
- Pediatrics
- Gastroenterology
- Pharmacology
Background:
- Acute diarrhea is a common pediatric illness, leading to dehydration and requiring effective management.
- Oral rehydration salts (ORS) are a standard treatment, but additional agents may improve efficacy.
Purpose of the Study:
- To evaluate the efficacy of ORS combined with gelatin tannate compared to ORS alone in treating acute diarrhea in children.
- To assess the impact on stool frequency and other clinical parameters.
Main Methods:
- A cohort study involving pediatric patients (3 months to 12 years) with acute diarrhea (≥3 liquid stools/day, <72h duration).
- Patients received either ORS alone or ORS plus gelatin tannate.
- Primary endpoint: number of stools at 12 hours; secondary: Stool Decrease Index (SDI), vomiting, dehydration, weight, and signs of peritonitis/sepsis.
Main Results:
- The ORS + gelatin tannate group showed a significantly greater Stool Decrease Index (SDI) (-0.6023) compared to the ORS-only group (-0.1894) (p < 0.0001).
- This corresponds to a 60% decrease in stools for the ORS + gelatin tannate group versus an 18% decrease for the ORS group.
- No significant differences were observed in other clinical variables, though a trend towards improvement was noted.
Conclusions:
- Gelatin tannate, when added to ORS, significantly reduces stool frequency in pediatric acute diarrhea.
- The combination therapy demonstrates superior efficacy in decreasing stool output compared to ORS alone.
- Gelatin tannate represents a promising adjunct therapy for managing acute diarrhea in children.
Aim:
The study aims to observe the response to treatment with ORS only or ORS + gelatin tannate in two cohorts of pediatric patients with acute diarrhea, with the primary efficacy endpoint being the number of stools at 12 hours from baseline.
Methods:
Children aged 3 months to 12 years were included in the study. Only children with acute diarrhea, more than 3 liquid stools, and duration inferior to 72 h were included. Number of stools was recorded as absolute number, categorized as
Results:
Baseline characteristics for the two populations included a mean age of 2.3 years in the ORS group and 2.6 years in the ORS + gelatin tannate group. Children younger than 2 years represented 59.8 and 54.3% in the ORS and ORS + gelatin tannate groups, respectively. Clinical variables such as vomiting, dehydration, weight, and stool decrease index were used to compare the two groups. We found a statistical significant difference between the two groups (p < 0.0001) -- SDI for the ORS group was -0.1894; for the ORS + gelatin tannate group was -0.6023.
Conclusions:
We observed a significant decrease in the number of stools and an improvement in the consistency of stools in the ORS + gelatin tannate group. Other clinical variables such as vomiting, dehydration, weight, bloody stools, and peritonitis/sepsis signs showed no statistical differences between the two groups, but did show a general trend toward improvement. The Stool Decrease Index (SDI) showed a 18% decrease in the number of stools for the ORS group and 60% for the ORS + gelatin tannate group. The use of ORS + gelatin tannate was associated with a greater decrease in SDI. Gelatin tannate decreased the number of stools at twelve hours in children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Stringent Response in E. coli
Pharmacokinetics in Pediatric Patients: Drug Excretion